CYANOPYRROLIDINE DERIVATIVES

Application 679/CHENP/2003 published 2005-04-15, filed 2003-05-06
"Cyanopyrrolidine derivatives represented by the general formula (1) or pharmaceutically acceptable salts thereof: (1) wherein R1 is halogeno, hydroxyl, or the like, and R2 is hydrogen, halogeno, or the like, or alternatively R1 and R2 are united to form oxo, hydroxyimino, or the like; R3 and R4 are each hydrogen, halogeno, or the like, or alternatively R3 and R4 are united to form oxo, hydroxyimino, or the like; X is oxygen or sulfur; Y is CR5R6- (wherein R5 and R6 are each independently hydrogen, halogeno, or the like) or CR7R8-CR9R10- (wherein R7, R8, R9, and R10 are each independently hydrogen, halogeno, or the like, or alternatively R7 and R9 together with the carbon atoms adjacent thereto form C3-8 cycloalkyl or the like); and Z is hydrogen, C1-10 alkyl,or the like, or alternatively Y and Z together with the nitrogen atom adjacent thereto form cyclic C2-10 amino or the like."

Applicant

TAISHO PHARMACEUTICAL CO., LTD.
24-1, Takata 3-chome, Toshima-ku, Tokyo 170-8633, Japan; a Japanese body corporate

Inventor

International Info

Classification: C07D 207/16
Publication Number: PCT/JP01/09818

Priority Information

344036/2000 Japan 2000-11-10